SUDEEPPHRM
Sudeep Pharma Limited (SUDEEPPHRM) Stock Analysis
Sudeep Pharma Limited manufactures pharmaceutical APIs and advanced intermediates for regulated markets. It supplies niche APIs with focus on quality and compliance for global generics customers. The company operates manufacturing facilities in Gujarat. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹1,000.70
-4.72% 1W | +36.30% 52W
Market Cap
11.3k CR
P/E Ratio
61.4
52W High
₹1378
52W Low
₹524
Div. Yield
0.15%
Beta
–
50 DMA
₹1151.4
200 DMA
₹807.7
Profit Margin
27%
Inst. Own.
6.8%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 116 | 158 | 125 | 163 | 172 | 182 | 158 |
| Expenses | 85 | 76 | 99 | 81 | 107 | 112 | 120 | 103 |
| Operating Profit | 63 | 39 | 59 | 44 | 55 | 60 | 63 | 55 |
| OPM % | 43% | 34% | 37% | 35% | 34% | 35% | 34% | 35% |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | 5 |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 62 | 38 | 58 | 44 | 60 | 62 | 63 | 54 |
| Tax % | 21% | 24% | 24% | 29% | 21% | 23% | 23% | 25% |
| Net Profit | 49 | 29 | 44 | 31 | 47 | 48 | 49 | 41 |
| EPS in Rs | 5.80 | 2.95 | 4.54 | 3.17 | 4.71 | 4.20 | 4.33 | 3.59 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 123 | 215 | 343 | 429 | 459 | 502 | 642 | 676 |
| Expenses | 98 | 171 | 276 | 338 | 276 | 310 | 419 | 443 |
| Operating Profit | 25 | 44 | 67 | 90 | 183 | 192 | 223 | 233 |
| OPM % | 21% | 20% | 20% | 21% | 40% | 38% | 35% | 34% |
| Other Income | 3 | 3 | 7 | 9 | 6 | 9 | 28 | 29 |
| Interest | 1 | 1 | 2 | 6 | 5 | 7 | 8 | 8 |
| Depreciation | 3 | 4 | 5 | 8 | 9 | 11 | 15 | 16 |
| Profit before tax | 25 | 43 | 69 | 86 | 175 | 183 | 228 | 238 |
| Tax % | 27% | 22% | 27% | 28% | 24% | 24% | 24% | |
| Net Profit | 18 | 33 | 50 | 62 | 133 | 139 | 174 | 184 |
| EPS in Rs | 2.15 | 3.97 | 5.97 | 7.42 | 15.86 | 14.27 | 15.31 | 16.83 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 14.0% | 24.0% | – |
| Profit CAGR | 40.0% | 39.0% | – |
Shareholding Pattern
Promoters76.16%
FIIs1.67%
DIIs17.59%
Public4.57%
Promoters76.16%
FIIs1.55%
DIIs18.11%
Public4.18%
Promoters76.16%
FIIs1.81%
DIIs15.64%
Public6.39%
Promoters76.16%
FIIs2.93%
DIIs14.06%
Public6.87%
Promoters76.16%
FIIs1.55%
DIIs18.11%
Public4.18%
Promoters76.16%
FIIs2.93%
DIIs14.06%
Public6.87%
SUDEEPPHRM
Holdings Analysis
Key strengths & risk signals
73
Overall
86
Fundamental
61
Technical
Risks (3)
NEGLIGIBLE DIVIDEND! 0.15% yield - little to no income.
RECOVERY MODE! Current price (1000.7) above 200-day but below 50-day.
WEAK MOMENTUM! Limited price growth - -4.7% (1 week), -9.6% (1 month), 16.0% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1151.4) is above 200-day average (807.7) - positive signal.
GOOD YEAR! Stock gained 36.3% in the last year.
APPROACHING OVERSOLD! RSI at 36.1 - watch for reversal.
Fundamental & Technical Analysis
73Overall
86Fundamental
61Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 14.4% (GOOD, 11/15). Profit CAGR: 40.5% (EXCELLENT, 15/15).
Profit Margin
9/10
EXCELLENT EFFICIENCY! 27.0% profit margin - company keeps strong profits.
PEG Valuation
8/10
FAIRLY VALUED! PEG of 1.52 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.15% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.28 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 4.57% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1151.4) is above 200-day average (807.7) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1000.7) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
10/10
GOOD YEAR! Stock gained 36.3% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 242,172 vs down days: 257,391. Ratio: 0.94x
RSI
4/5
APPROACHING OVERSOLD! RSI at 36.1 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 55.8% of 52W range - neutral zone.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -4.7% (1 week), -9.6% (1 month), 16.0% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
SUDEEPPHRM
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-11 | Concall PDF | |
| Q4FY262026-05-28 | Concall PDF | |
| Q3FY262026-02-12 | Concall PDF | |
| Q2FY262025-12-25 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUDEEPPHRM | ₹1,000.70 | 61.4 | 27.0% | 14.4% | 40.5% | +36.3% | 73 | BREAKDOWN | +31.8% | -17.0% | +26.7% | -13.2% |
| AKUMS | ₹731.50 | 38.4 | 6.5% | 7.0% | 39.1% | +62.4% | 76 | BREAKDOWN | +57.5% | +18.2% | +13.9% | +0.8% |
| VIYASH | ₹226.00 | 55.3 | 5.9% | 33.3% | – | +15.1% | 60 | BOUNCE FROM SUPPORT | +107.2% | +26.5% | +19.6% | +2.9% |
| STAR | ₹1,045.20 | 15.7 | 12.3% | 8.7% | – | +34.5% | 64 | BREAKDOWN | +57.5% | +23.6% | +13.0% | -4.4% |
| SEQUENT | ₹201.20 | 123.4 | 2.5% | 3.1% | -18.9% | +26.2% | 55 | CONSOLIDATION | -13.9% | +161.2% | +10.9% | +102.5% |
| SUVEN | ₹303.60 | – | – | -19.3% | – | +49.1% | 55 | BREAKDOWN | +147.8% | +179.8% | +89.5% | +140.0% |
| PGHL | ₹5,200.00 | 24.2 | 24.9% | 8.2% | 19.3% | -16.2% | 71 | CONSOLIDATING DOWN | +45.3% | +1.7% | +7.4% | -1.8% |
| NATCOPHARM | ₹785.00 | 12.4 | 32.8% | 14.5% | 25.6% | -4.8% | 66 | APPROACHING SUPPORT | -57.0% | -22.9% | -44.7% | -0.5% |
Data from TradeAlone · Updated daily
SUDEEPPHRM News
Sudeep Pharma Limited (sudeepphrm) FDA Approval Enables New Pharma Greenfield Facility Operations2026-10-26Sudeep Pharma Limited (SUDEEPPHRM) breaks out, gains 8% intraday2026-08-11Sudeep Pharma Limited (SUDEEPPHRM) clears resistance, moves up 10% intraday2026-08-10Sudeep Pharma Limited (SUDEEPPHRM) breaks out, gains 5% intraday2026-08-10Sudeep Pharma Limited (SUDEEPPHRM) gains 10% intraday, breaks out2026-08-05Sudeep Pharma Limited (SUDEEPPHRM) sees profit-taking after breakout, falls 5%2026-08-05Sudeep Pharma Limited (SUDEEPPHRM) gains 5% intraday2026-07-31Sudeep Pharma Limited (SUDEEPPHRM) gains 5% intraday2026-07-27Sudeep Pharma Limited (SUDEEPPHRM) sees profit-taking after breakout, falls 5%2026-07-06Sudeep Pharma Limited (SUDEEPPHRM) pulls back after breakout, pulls back after down 5% intraday2026-06-25Sudeep Pharma Limited (SUDEEPPHRM) breaks out, moves up 5% intraday2026-06-17Sudeep Pharma Limited (SUDEEPPHRM) breaks out +8%2026-06-15Sudeep Pharma Limited (SUDEEPPHRM) surges 10% on strong outlook2026-06-15
